Patents by Inventor MARK WOGULIS

MARK WOGULIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9688975
    Abstract: The present invention relates to beta-glucosidase variants, e.g. beta-glucosidase variants of a parent Family GH3A beta-glucosidase from Aspergillus fumigatus. The present invention also relates to polynucleotides encoding the beta-glucosidase variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the beta-glucosidase variants.
    Type: Grant
    Filed: September 30, 2011
    Date of Patent: June 27, 2017
    Assignee: Novozymes, Inc.
    Inventors: Mark Wogulis, Paul Harris, David Osborn
  • Publication number: 20170175097
    Abstract: The present invention relates to variants of a parent cellobiohydrolase II. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: March 1, 2017
    Publication date: June 22, 2017
    Inventor: Mark Wogulis
  • Patent number: 9676830
    Abstract: The present invention relates to chimeric GH61 polypeptides having cellulolytic enhancing activity. The present invention also relates to polynucleotides encoding the chimeric GH61 polypeptides; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the chimeric GH61 polypeptides.
    Type: Grant
    Filed: November 18, 2011
    Date of Patent: June 13, 2017
    Assignee: Novozymes, Inc.
    Inventors: Mark Wogulis, Matthew Sweeney, Tia Heu
  • Patent number: 9611463
    Abstract: The present invention relates to variants of a parent cellobiohydrolase II. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: October 13, 2014
    Date of Patent: April 4, 2017
    Assignee: Novozymes, Inc.
    Inventor: Mark Wogulis
  • Publication number: 20170051262
    Abstract: The present invention relates to isolated polypeptides having amylolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: October 20, 2016
    Publication date: February 23, 2017
    Applicant: NOVOZYMES, INC.
    Inventors: Paul Harris, Mark Wogulis
  • Patent number: 9506046
    Abstract: The present invention relates to isolated polypeptides having amylolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Grant
    Filed: November 2, 2009
    Date of Patent: November 29, 2016
    Assignee: Novozymes, Inc.
    Inventors: Paul Harris, Mark Wogulis
  • Publication number: 20160122737
    Abstract: The present invention relates to xylanase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: May 30, 2014
    Publication date: May 5, 2016
    Applicant: NOVOZYMES A/S
    Inventor: Mark Wogulis
  • Publication number: 20150082493
    Abstract: The present invention relates to GH61 polypeptide variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: April 26, 2013
    Publication date: March 19, 2015
    Inventors: Janine Lin, Doreen Bohan, Michelle Maranta, Leslie Beresford, Michael Lamsa, Matt Sweeney, Mark Wogulis, Elizabeth Znameroski, Frank Winther Rasmussen
  • Publication number: 20150031080
    Abstract: The present invention relates to variants of a parent cellobiohydrolase II. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: October 13, 2014
    Publication date: January 29, 2015
    Inventor: Mark Wogulis
  • Publication number: 20150004655
    Abstract: The present invention relates to cellobiohydrolase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of producing and using the variants.
    Type: Application
    Filed: December 20, 2012
    Publication date: January 1, 2015
    Inventor: Mark Wogulis
  • Publication number: 20140329284
    Abstract: The present invention relates to chimeric polypeptides having beta-glucosidase activity.
    Type: Application
    Filed: September 28, 2012
    Publication date: November 6, 2014
    Inventors: Mark Wogulis, David Osborn, Tia Heu
  • Patent number: 8859253
    Abstract: The present invention relates to variants of a parent cellobiohydrolase II. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: October 14, 2014
    Assignee: Novozymes, Inc.
    Inventor: Mark Wogulis
  • Patent number: 8828701
    Abstract: The present invention relates to variants of a parent cellobiohydrolase. The present invention also relates to polynucleotides encoding the cellobiohydrolase variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the cellobiohydrolase variants.
    Type: Grant
    Filed: March 29, 2011
    Date of Patent: September 9, 2014
    Assignee: Novozymes, Inc.
    Inventor: Mark Wogulis
  • Publication number: 20140059719
    Abstract: The present invention relates to chimeric GH61 polypeptides having cellulolytic enhancing activity. The present invention also relates to polynucleotides encoding the chimeric GH61 polypeptides; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the chimeric GH61 polypeptides.
    Type: Application
    Filed: November 18, 2011
    Publication date: February 27, 2014
    Applicant: Novozymes, Inc.
    Inventors: Mark Wogulis, Matthew Sweeney, Tia Heu
  • Publication number: 20140017737
    Abstract: The present invention relates to variants of a parent cellobiohydrolase II. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: September 23, 2013
    Publication date: January 16, 2014
    Inventor: Mark Wogulis
  • Patent number: 8541651
    Abstract: The present invention relates to variants of a parent cellobiohydrolase II. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: October 20, 2010
    Date of Patent: September 24, 2013
    Assignee: Novozymes, Inc.
    Inventor: Mark Wogulis
  • Publication number: 20130227748
    Abstract: The present invention relates to polypeptide having cellulolytic enhancing activity variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: September 29, 2011
    Publication date: August 29, 2013
    Applicant: Novozymes, Inc.
    Inventors: Matt Sweeney, Mark Wogulis
  • Publication number: 20130219568
    Abstract: The present invention relates to polypeptide having cellulolytic enhancing activity variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: September 29, 2011
    Publication date: August 22, 2013
    Applicant: Novozymes, Inc.
    Inventors: Matthew Sweeney, Mark Wogulis
  • Publication number: 20130217079
    Abstract: The present invention relates to variants of a parent beta-glucosidase. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: September 30, 2011
    Publication date: August 22, 2013
    Applicant: Novozymes, Inc.
    Inventors: Mark Wogulis, Paul Harris, David Osborn
  • Publication number: 20130040346
    Abstract: The present invention relates to variants of a parent cellobiohydrolase. The present invention also relates to polynucleotides encoding the cellobiohydrolase variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the cellobiohydrolase variants.
    Type: Application
    Filed: March 29, 2011
    Publication date: February 14, 2013
    Applicant: NOVOZYMES, INC.
    Inventor: Mark Wogulis